Babraham Investor Conference (BIC) is a must attend one-day conference for investors focusing on early-stage and scale-up life science and med-tech companies from across the UK and Europe taking place on Wednesday 15th May 2019 at the Babraham Research Campus, Cambridge, UK.
We are now calling for companies to apply to present at Start-up and Scale-up sessions. Applications close 5th April 2019.
Typically, presenting companies will be seeking funding of between £250K to £20M. Presenting slots of 15 minutes each (including Q&A) are available. There is also ample time for networking in-between sessions and the opportunity to have an exhibition stand. There is no charge to apply, however, we do request a fee of £100+VAT from each company successful in securing a slot to present.
To apply to present email us using the link below and you will receive a non-confidential investment profile to complete. All applications are reviewed by our panel and successful companies will be contacted via email.
Our programme is currently in development and will feature a rich programme of company presentations and networking opportunities. During the course of the day you can expect:
As Head of Seed Funds at Cambridge Enterprise, Anne has overseen strong growth in our investment activities, with Seed Funds investing over £5 million each year in young companies.
Dr Ian Tomlinson is Chairman of the Board of the Stevenage Bioscience Catalyst, Chairman of the Investment Committee of Apollo Therapeutics and is a member of the Major Awards Committee for the UK governments BioMedical Catalyst funding scheme.
Handelsbanken is a full-service bank with a decentralised way of working, a strong local presence due to a nationwide network of over 200 branches and a long-term approach to customer relations.
(+44) 1223 496 000
Babraham Bioscience Technologies Ltd
Babraham Research Campus
CB22 3AT, United Kingdom
01223 813 557